欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
NL/H/2026/002
药品名称
Candesartan 8 mg
活性成分
candesartancilexetil 8.0 mg
剂型
Tablet
上市许可持有人
Teva Nederland B.V., Swensweg 5, 2031 GA Haarlem, The Netherlands
参考成员国 - 产品名称
Netherlands (NL)
互认成员国 - 产品名称
许可日期
2010/06/25
最近更新日期
2020/01/28
药物ATC编码
C09CA06 candesartan
申请类型
TypeLevel1:
Abridged
TypeLevel2:
Additional Strength/Form
TypeLevel3:
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final Labelling
|
1_3_1 label outer _eu_clean
Date of last change:2024/09/06
Final PL
|
1_3_1 pil_eu clean
Date of last change:2024/09/06
Final SPC
|
1_3_1 spc_eu clean2_OK
Date of last change:2024/09/06
Final Product Information
|
common_outer_clean
Date of last change:2024/09/06
Final Product Information
|
common_pl_candesartanclean
Date of last change:2024/09/06
Final Product Information
|
common_spc_candesartanclean
Date of last change:2024/09/06
PubAR
|
PAR_2026_DC_candesartan_21 okt 2010
Date of last change:2024/09/06
市场状态
Withdrawn(注:已撤市)
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase